HIV Flashcards
HIV-1
- Responsible for most cases of AIDS in the US
Antigenicically disntinct genotypes of HIV-1
- Groups M, O, N, P
- Group M is responsible for the global AIDS epidemic
Group M HIV genotype
- Based on sequence differences of env and gag genes
- results in antigenicity differences b/w gp120 and capsid proteins
- Subtype B predominates in US
Clades definition
- Varying subtypes of a gene
Essential genes (all retroviruses)
- gag (group antigens) gene
- pol (polymerase) gene
- env (envelope) gene
Gag gene
- Essential gene of retroviruses
- Encodes:
*matrix protein (p17)
*capsid protein (p24)
*nucleocapsid (p9)
Pol gene
- Essential gene of retroviruses
- Encodes:
*protease (p10)
*reverse transcriptase (p50)
*RNase (p15)
*integrase (p31)
Env gene
- Essential gene of retroviruses
- Encodes:
*surface subunit (gp120)
*transmembrane subunit (gp41)
HIV regulatory (accessory) genes
- tat
- rev
- nef
- vif
- vpu
- vpr
- These genes enhance the replication and infectivity to counter some host defense mechanisms
Tat gene
- HIV regulatory gene
- transactivates transcription of HIV genes
Rev gene
- HIV regulatory gene
- regulates RNA splicing and promotes export of mRNA to the cytoplasm
Nef gene
- HIV regulatory gene
- Reduces cell surface expression of CD4 and MHC class I; alters T cell signaling pathways; required to maintain high viral loads; essential for progression to AIDS
Vif gene
- HIV regulatory gene
- Promotes assembly; blocks a cellular antiviral protein that produces hypermutations during cDNA transcription
Vpu gene
- HIV regulatory gene
- Facilitates release of virus by countering a cellular protein that tethers virions to the infected cell; induces degradation of cell surface CD4
Vpr gene
- HIV regulatory gene
- Transports cDNA to the nucleus; induces cell cycle arrest; facilitates replication in myeloid cells
Long Terminal Repeats (LTR)
- On either end of the HIV genome
- Contains promoters and sequences used as binding sites by transcription factors
- Activated cells produce transcription factors that bind LTR and activate transcription of viral genes
- Activated T cells can be productively infected by HIV and generate progeny virions
- Resting T cells are not productively infected by HIV
*incomplete viral cDNA transcripts accumulate or
*proviral DNA is made but does not integrate into the host chromosome (pre-integration latency)
HIV replication outline
- Viral attachment and entry
- Genomic RNA reverse transcribed into cDNA
- cDNA enter the nucleus and integrates into host chromosomes
- Transcription/translation of genes from the proviral DNA template
- Assembly of a premature particle and budding through the plasma membrane
- Maturation into infectious virus
HIV Attachment and entry
- Host cell receptors:
*CD4; primary co-receptor to HIV gp120
*chemokine receptors (CCR-5, CXCR-4); primary co-receptor to HIV gp120
*alpha-4 beta-7 integrin (GALT homing receptor for activated T-cells)
*DC-SIGN (intercellular adhesion molecule on dendritic cells)
- Viral attachment
*gp120
- Entry
*virus-cell fusion at the plasma membrane
*receptor-mediated endocytosis- fusion at the endosomal membrane
*mediated by gp41 (activated only when both co-receptors (CD4, chemokine) are bound by HIV ligand (gp120)
Assembly and Maturation of HIV
- Assembly at the cell surface
*gag and gag-pol polyprotein precursors package viral RNA genome
- Budding through the cell membrane
*acquires lipid envelope w/gp120 and gp41
- Maturation into infectious virus
*HIV protease cleaves gag and gag-pol polyprotein into individual proteins- changes the viral particle into a fully infectious one
*protease inhibitors inhibit this processing so mature proteins are not produced
Classes of antiretrovirals
- Nucleoside reverse transcriptase inhibitors (NRTIs); nucleoside analogues
- Non-nucleoside reverse transcriptase inhibitors (NNRTI)
- Protease inhibitors
- Attachment/Entry inhibitors
*fusion inhibitors
*CCR5 inhibitor
- Integrase inhibitors
Nucleoside reverse transcriptase inhibitors
- Zidovudine (azidothymidine or AZT)
- Requires phosphorylation for activation
*cellular enzymes carry out all 3 phosphorylation steps
- The activated drug binds to and inhibits RT
- Incorporation into the DNA strand results in chain termination
- Resistance is due to mutations in the HIV RT
*encoded by the pol gene
Non-nucleoside reverse transcriptase inhibitors
- Nevirapine
- Does not require phosphorylation for activation
- Bind to RT at a site distinct from the active site, but inhibit its activity
- Inhibit HIV-1 RT, but not HIV-2 RT
- Resistance is due to mutations in RT, distinct from those responsible for resistance to NRTIs
Protease inhibitors
- Saquinavir
- Small molecules that bind in the enzymatic pocket of HIV protease
- Inhibition of the protease inhibits the maturation of infectious viral particles
- Resistance is due to mutations in the protease (pol gene)
*cross resistance b/w protease inhibitors is common
Fusion inhibitors
- Enfuvirtide
- 36 amino acid peptide that binds to gp41
- Blocks the conformational change that occurs after gp120 bind to CD4
- gp41 is unable to mediate fusion b/w the viral envelope and the host cell membrane
*entry is inhibited
- Resistance will occur if HIV mutates the binding site of enfuvirtide